SOFINNOVA-PARTNERS
13.12.2023 07:01:34 CET | Business Wire | Press release
Sofinnova Partners (“Sofinnova"), a leading European life sciences venture capital firm based in Paris, London, and Milan, announced today the launch of Biovelocita, an investment strategy dedicated entirely to the creation and acceleration of biotech startups in Europe.
Biovelocita’s newly formed team will provide a hands-on, robust framework for startups, combining direct management, financial backing, and access to Sofinnova’s extensive infrastructure and network. The strategy builds upon Sofinnova’s established track record of nurturing innovative ventures within the healthcare and sustainability sectors. It draws inspiration from the achievements of Italy’s first biotech accelerator, BiovelocITA, co-founded by Gabriella Camboni, Silvano Spinelli and Sofinnova Partners in 2015, which has significantly contributed to the growth of the Italian biotech ecosystem.
Graziano Seghezzi, Managing Partner of Sofinnova Partners, said: “With Sofinnova Biovelocita, we are doubling down on our commitment to innovation and company creation in the life sciences. To improve and expand our company-creation toolbox, we have brought together a group of experienced investors and entrepreneurs who have been collaborating with Sofinnova for over a decade, some nearly two decades. With this top-tier team, we look forward to strengthening one of Sofinnova’s strategic pillars: acceleration, which is already making rapid strides in the medical device space with Sofinnova MD Start, our in-house medtech accelerator.”
Key partners of this initiative include:
- Gabriella Camboni, Partner, pivotal in the conception of this strategy as a co-founder and CEO of BiovelocITA. She also co-founded two Sofinnova companies, EOS (Ethical Oncology Science), serving as its COO until its acquisition by Clovis Oncology in 2013, and Novuspharma, which was acquired by Cell Therapeutics, Inc. in 2003.
- Matthieu Coutet, Partner, brings nearly two decades of experience in venture capital and operations, including significant contributions to the launch of biotech startups such as TherAchon and Annapurna Therapeutics, and the founding of AdBio Partners.
- Alex Leech, Partner, an experienced biopharma company builder and a serial CEO, most recently serving as the founding CEO of Alchemab Therapeutics, which raised an $82m Series A investment round.
- Zhizhong (Joel) Yao, Partner, a former Principal in the Sofinnova Capital Strategy, and a Kauffman Fellow, instrumental in the launch of several biotech start-ups. Holds a Harvard PhD in Chemical Biology and Systems Biology and did post-doctoral research at the French National Institute of Agricultural Research.
Seghezzi concluded: “We know from our extensive experience that close cooperation between top management teams, world-class scientists, and dedicated financing, forges the path for biotech champions of tomorrow. With this new strategy, we are poised to catalyze transformative innovation in biotechnology.”
About Sofinnova Partners
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to positively impact our collective future.
Founded in 1972, Sofinnova Partners is a deeply established venture capital firm in Europe, with 50 years of experience backing over 500 companies and creating market leaders around the globe. Today, Sofinnova Partners has over €2.5 billion under management. For more information, please visit: sofinnovapartners.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231212907842/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Torq Acquires Jit to Unleash the First Enterprise AI SOC Context Graph—and Rewrite the Future of SecOps19.5.2026 15:00:00 CEST | Press release
With Jit Acquisition, Torq Catapults Enterprise SOCs Into a New Realm of Detailed Contextual Investigations That Drive Precision Decision-Making Torq, the established agentic security operations leader, today announced the acquisition of Jit, the Boston-based AI Context Graph cybersecurity pioneer. This move marks a dramatic leap forward for the Torq AI SOC Platform by ensuring agentic investigations are precisely informed via organization-specific contextual data. This shift redefines agentic reasoning, moving beyond static facts such as users, devices and their relationships, to prioritize live, dynamic contextual data overlaid on top, including business drivers, and the real-time state of the enterprise. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260519044833/en/ Instead of acting on fragmented data or having investigations triggered by a single alert, Torq AI operates with a unified, continuously-updated, contextual
Nine in 10 Firms Fear In-House Systems Can’t Keep Pace with Executive Pay Demands19.5.2026 15:00:00 CEST | Press release
89% of senior HR, rewards, and compensation leaders say in-house technology cannot keep pace with executive compensation demands80% report increased participation in incentive schemes over the past three years66% identify reliance on multiple service providers as a key barrier to maintaining accurate and consistent data Managing executive compensation is a growing challenge for financial services firms, with nearly nine in 10 (89%) saying their in-house technology can’t keep pace with demand. New research by CSC, the leading provider of business administration and compliance solutions, shows that rising complexity, regulatory pressure, and expanding global participation place increasing strain on internal systems and teams.1 CSC surveyed 300 senior HR, rewards, and compensation leaders across Europe, Asia Pacific, and North America working in private markets, asset management, insurance, and investment banking. The report, The Future of Reward in Financial Services: Executive Compensat
Tacton Appoints Manufacturing Technology Leader Mike DiTullio to Board of Directors19.5.2026 15:00:00 CEST | Press release
Former PTC President & COO brings decades of experience serving complex manufacturers and scaling global commercial organizations as Tacton advances growth in North America and EMEA. Tacton, a global leader in Configure, Price, Quote (CPQ) solutions for manufacturers of complex products, today announced the appointment of Mike DiTullio to its Board of Directors. DiTullio is an enterprise software executive with more than three decades of experience working with complex manufacturers. He joins at a pivotal moment in the company’s evolution as Tacton expands beyond CPQ to deliver the Buyer-Centric Smart Factory, a connected approach that unites buyer engagement, engineering, and order fulfillment into a single intelligent system. DiTullio spent 26 years at PTC, most recently as President and Chief Operating Officer, wherehe worked closely with leading manufacturers to transform how they design, sell, and deliver complex products. In that role, he led global commercial operations across s
Echodyne and Moog SuccessfullyDemonstrate Reconfigurable Integrated-weapon Platform (RIwP®) at U.S. Army Exercise19.5.2026 15:00:00 CEST | Press release
Demonstration showed how combining advanced radar, sophisticated control systems, and AI can turn existing kinetic weapons into highly effective C-UAS effectors Echodyne, the radar platform company, and Moog Inc. (NYSE: MOG.A and MOG.B), a worldwide designer, manufacturer, and systems integrator of high performance precision motion and control systems, announce the results of testing of their defensive systems to counter small offensive UAS (“sUAS”) weapons. Capabilities Tested Live detection, lock on with precision tracking, and successfully engaging of Group 1-3 UAS threats in less than 3 seconds. Combined AI targeting, wireless fire control, and radar integration across mission equipment capabilities for defense against small UAS weapons. AI targeting for passive detection, autonomous targeting, track re-acquire, multi-object targeting. Outputs Identified and swiftly rectified critical capability gaps within a simulated battlefield environment. Proved that combining precision data w
NordicTrack’s Most Ambitious Pilates Machine Yet: Introducing the Ultra 1 Reformer19.5.2026 15:00:00 CEST | Press release
NordicTrack is bringing studio-grade Pilates directly into the home with the Ultra 1 Reformer, available to order May 19 at NordicTrack.com for $US4,999. Blending luxury craftsmanship with smart technology, this consumer-focused model offers a studio‐quality Pilates experience that fits effortlessly into modern living. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260519139005/en/ NordicTrack Ultra 1 Reformer Pilates has become a cornerstone of modern wellness, recognized for building core strength, improving flexibility, and fostering a deep mind-body connection. Recognizing this growing demand, NordicTrack’s new reformer pairs elegant design with an integrated HD touchscreen and seamless access to expert‐led classes through the iFIT platform. “The Ultra 1 Reformer is the first Pilates machine that earns its place in your home. Real equipment, personalized expert instruction, and the results we are all seeking,” says Kevin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom